Company Description:

Moderna, Inc. is a biotechnology company that revolutionized medicine through its mRNA technology. It focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA (mRNA).

The company was founded by Derrick Rossi, Kenneth R. Chien, Robert Langer, and Noubar Afeyan in 2010 and is headquartered in Cambridge, Massachusetts, United States. Moderna has been at the forefront of developing a series of mRNA therapeutics and vaccines, including one of the first and most widely used COVID-19 vaccines.

Main Product(s):

Moderna's primary products are mRNA-based vaccines and therapies, with its most notable product being the Moderna COVID-19 vaccine. The company also focuses on developing mRNA treatments for other infectious diseases, cancer, and rare genetic diseases.

Short History of Moderna, Inc:

• 2010 – Moderna was founded by a team of scientists and entrepreneurs.
• December 2016 – The company entered into a collaboration with AstraZeneca for treating cardiovascular, metabolic, and renal diseases as well as cancer.
• March 2020 – Moderna shipped its first COVID-19 vaccine batches for Phase 1 trials, marking a significant step in the pandemic response.
• December 2020 – The FDA authorized the emergency use of Moderna’s COVID-19 vaccine.
• 2021 and Beyond – Moderna continued to expand its mRNA technology applications in various treatments, including vaccines for other infectious diseases and cancer research.